LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)

AstraZeneca900 enrolled

Overview

Evaluate burden of disease in Patients with newly occurred upper GI symptoms related to GERD (symptom frequency \& severity, QoL, lifestyle modifications, self-medication) - baseline data according to GERD impact scale presenting to specialists, especially internists \- Evaluate effect of treatment with a acid suppressive therapy on these parameters: looking for improvement of symptom burden and quality of life according to the GERD impact sca

Study Type

OBSERVATIONAL

Enrollment

900

Conditions

GERD

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with newly occured upper GI symptoms related to GERD

Locations (1)

Research Site

Vienna, Austria

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.